Age-related clonal hematopoiesis associated with adverse outcomes.

Genomic Classification and Prognosis in Acute Myeloid Leukemia. N Engl J Med (2016) 4.49

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes. N Engl J Med (2016) 3.41

Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science (2015) 3.29

Clonal hematopoiesis associated with Tet2 deficiency accelerates atherosclerosis development in mice. Science (2017) 2.77

Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia. JAMA (2015) 2.73

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood (2014) 2.54

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood (2015) 2.46

Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis. Cell Rep (2015) 1.83

Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development. Cancer Cell (2016) 1.57

MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance. Blood (2015) 1.52

Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations. Nature (2017) 1.50

Visualizing the origins of selfish de novo mutations in individual seminiferous tubules of human testes. Proc Natl Acad Sci U S A (2016) 1.44

DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling. Nat Med (2016) 1.42

Frequent Somatic Mutation in Adult Intestinal Stem Cells Drives Neoplasia and Genetic Mosaicism during Aging. Cell Stem Cell (2015) 1.42

RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML. Cell Stem Cell (2016) 1.42

Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia. Cancer Genet (2015) 1.31

Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia. Cancer Cell (2015) 1.25

Tissue-specific mutation accumulation in human adult stem cells during life. Nature (2016) 1.24

Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma. Haematologica (2016) 1.23

An update of current treatments for adult acute myeloid leukemia. Blood (2015) 1.23

Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia. Blood (2015) 1.21

Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms. Cancer Discov (2015) 1.17

Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance. Blood (2015) 1.16

Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis. Blood Cancer J (2015) 1.15

TET proteins and the control of cytosine demethylation in cancer. Genome Med (2015) 1.13

Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution. Nat Genet (2016) 1.12

Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials. Drug Discov Today (2015) 1.12

Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network. Nat Genet (2015) 1.11

Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer. Cell Stem Cell (2015) 1.11

Post-zygotic Point Mutations Are an Underrecognized Source of De Novo Genomic Variation. Am J Hum Genet (2015) 1.09

Somatic mosaicism: implications for disease and transmission genetics. Trends Genet (2015) 1.08

Role of TET enzymes in DNA methylation, development, and cancer. Genes Dev (2016) 1.08

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood (2016) 1.05

Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia. Cell Stem Cell (2017) 1.05

Wnt activity and basal niche position sensitize intestinal stem and progenitor cells to DNA damage. EMBO J (2015) 1.04

Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia. Nat Med (2016) 1.01

Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes. Leukemia (2015) 1.01

Toward an evolutionary model of cancer: Considering the mechanisms that govern the fate of somatic mutations. Proc Natl Acad Sci U S A (2015) 0.99

Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents. Nat Commun (2016) 0.99

A tale of two siblings: two cases of AML arising from a single pre-leukemic DNMT3A mutant clone. Leukemia (2015) 0.98

Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults. Leuk Lymphoma (2015) 0.98

Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML. Blood (2015) 0.98

Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer. EBioMedicine (2016) 0.95

Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies. Nat Genet (2015) 0.94

Epigenetic Control of Stem Cell Potential during Homeostasis, Aging, and Disease. Cell Stem Cell (2015) 0.94

Transforming Cancer Prevention through Precision Medicine and Immune-oncology. Cancer Prev Res (Phila) (2016) 0.93

Myelodysplastic syndromes, version 2.2015. J Natl Compr Canc Netw (2015) 0.92

Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma. J Clin Oncol (2017) 0.92

Aging as a driver of leukemogenesis. Sci Transl Med (2015) 0.91

Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis. Leukemia (2015) 0.91

Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues. Proc Natl Acad Sci U S A (2016) 0.91

Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. Cancer Discov (2015) 0.90

Application of single-cell genomics in cancer: promise and challenges. Hum Mol Genet (2015) 0.90

IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association. Oncotarget (2015) 0.90

[Stress and optimal ageing]. Z Gerontol Geriatr (2015) 0.90

Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation. Leukemia (2016) 0.90

Clonal hematopoiesis in acquired aplastic anemia. Blood (2016) 0.89

Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia. Blood (2015) 0.89

Clone wars--the emergence of neoplastic blood-cell clones with aging. N Engl J Med (2014) 0.89

Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nat Commun (2016) 0.89

New insights into the generation and role of de novo mutations in health and disease. Genome Biol (2016) 0.88

Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors. J Clin Invest (2015) 0.88

Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis. J Exp Med (2015) 0.88

Therapy-related myeloid neoplasms - what have we learned so far? World J Stem Cells (2016) 0.87

Mosaic loss of chromosome Y is associated with common variation near TCL1A. Nat Genet (2016) 0.87

Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms. Blood (2017) 0.87

Aging, Clonality, and Rejuvenation of Hematopoietic Stem Cells. Trends Mol Med (2016) 0.86

The molecular pathogenesis of chronic lymphocytic leukaemia. Nat Rev Cancer (2016) 0.86

Advancing the Minimal Residual Disease Concept in Acute Myeloid Leukemia. Semin Hematol (2015) 0.86

Age-related mutations and chronic myelomonocytic leukemia. Leukemia (2015) 0.86

Inflamm-Aging of Hematopoiesis, Hematopoietic Stem Cells, and the Bone Marrow Microenvironment. Front Immunol (2016) 0.86

Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia. J Hematol Oncol (2017) 0.85

Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progression. Leukemia (2015) 0.85

Myelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing? Curr Hematol Malig Rep (2015) 0.85

Telomerase abrogates aneuploidy-induced telomere replication stress, senescence and cell depletion. EMBO J (2015) 0.84

Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation. Leukemia (2016) 0.84

Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms. Blood (2016) 0.84

Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance. Am J Med Genet A (2015) 0.84

Transfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes. BMC Genomics (2015) 0.84

Somatic mosaicism: on the road to cancer. Nat Rev Cancer (2015) 0.83

Loss of Y Chromosome in Peripheral Blood of Colorectal and Prostate Cancer Patients. PLoS One (2016) 0.83

Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study. Lancet Oncol (2016) 0.83

The landscape of somatic mutations in protein coding genes in apparently benign human tissues carries signatures of relaxed purifying selection. Nucleic Acids Res (2016) 0.83

Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified. Mod Pathol (2016) 0.83

Personalized medicine in myelodysplastic syndromes: wishful thinking or already clinical reality? Haematologica (2015) 0.82

Correlation of an epigenetic mitotic clock with cancer risk. Genome Biol (2016) 0.82

Detection of leukemia-associated mutations in peripheral blood DNA of hematologically normal elderly individuals. Leukemia (2015) 0.82

Mixed-phenotype acute leukemia (MPAL) exhibits frequent mutations in DNMT3A and activated signaling genes. Exp Hematol (2016) 0.82

Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion. Blood (2015) 0.82

Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise? Oncologist (2015) 0.82

Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications. Stem Cell Rev (2017) 0.81

Recent advances in understanding clonal haematopoiesis in aplastic anaemia. Br J Haematol (2017) 0.81

Analysis of cancer genomes reveals basic features of human aging and its role in cancer development. Nat Commun (2016) 0.81

The Fanconi anemia pathway is required for efficient repair of stress-induced DNA damage in haematopoietic stem cells. Cell Cycle (2015) 0.81

Stochastic modeling reveals an evolutionary mechanism underlying elevated rates of childhood leukemia. Proc Natl Acad Sci U S A (2016) 0.81

Predictors of survival in WHO-defined hypereosinophilic syndrome and idiopathic hypereosinophilia and the role of next-generation sequencing. Leukemia (2016) 0.81

CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression. Cell (2017) 0.81

Significance of myelodysplastic syndrome-associated somatic variants in the evaluation of patients with pancytopenia and idiopathic cytopenias of undetermined significance. Mod Pathol (2016) 0.81

Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance. Blood Cancer J (2016) 0.80

When stem cells grow old: phenotypes and mechanisms of stem cell aging. Development (2016) 0.80

Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med (2009) 33.09

Inflammation in atherosclerosis. Nature (2002) 28.92

The clonal evolution of tumor cell populations. Science (1976) 24.39

Signatures of mutational processes in human cancer. Nature (2013) 21.63

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med (2013) 19.87

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol (2013) 16.13

Macrophages, inflammation, and insulin resistance. Annu Rev Physiol (2010) 11.77

Discovery and saturation analysis of cancer genes across 21 tumour types. Nature (2014) 11.68

Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med (2011) 9.90

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature (2011) 9.71

The origin and evolution of mutations in acute myeloid leukemia. Cell (2012) 9.66

A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med (2002) 8.63

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med (2011) 7.89

Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell (2011) 7.41

Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell (2011) 7.37

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci U S A (2012) 7.14

Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature (2014) 6.83

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science (2008) 6.52

Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood (2013) 6.50

Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med (2008) 5.48

TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell (2011) 5.28

Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet (2011) 4.85

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood (2008) 4.41

Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia (2011) 4.28

Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci Transl Med (2012) 4.05

Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med (2009) 3.73

Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med (2009) 3.71

Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69

Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet (2012) 3.68

Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc Natl Acad Sci U S A (2014) 3.39

Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nat Genet (2012) 3.33

Genetic heterogeneity of diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A (2013) 3.25

Clonal diversity of recurrently mutated genes in myelodysplastic syndromes. Leukemia (2013) 2.85

Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. Blood (1996) 2.73

Red cell distribution width and all-cause mortality in critically ill patients. Crit Care Med (2011) 2.23

Large conserved domains of low DNA methylation maintained by Dnmt3a. Nat Genet (2013) 2.16

A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood (2013) 2.14

TET2 and DNMT3A mutations in human T-cell lymphoma. N Engl J Med (2012) 1.93

Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation. Nucleic Acids Res (2013) 1.70

Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations. Blood (2013) 1.65

Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma. Haematologica (2013) 1.40

Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes. Br J Haematol (1997) 1.17

Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications. Nat Genet (2013) 1.04

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46

A map of human genome variation from population-scale sequencing. Nature (2010) 121.13

The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res (2010) 97.51

A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39

MicroRNA expression profiles classify human cancers. Nature (2005) 69.12

Finding the missing heritability of complex diseases. Nature (2009) 67.95

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science (2004) 61.56

A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet (2011) 59.36

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet (2003) 53.59

Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science (2007) 51.70

The structure of haplotype blocks in the human genome. Science (2002) 50.88

A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science (2007) 43.16

Integrative genomics viewer. Nat Biotechnol (2011) 42.83

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09

A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science (2007) 37.88

Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06

Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science (2007) 32.97

The landscape of somatic copy-number alteration across human cancers. Nature (2010) 31.88

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature (2012) 31.78

Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02

Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21

Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol (2009) 27.17

Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet (2008) 25.83

Efficiency and power in genetic association studies. Nat Genet (2005) 25.56

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35

Detecting recent positive selection in the human genome from haplotype structure. Nature (2002) 22.00

Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet (2008) 20.73

Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet (2008) 20.66

Identification and importance of brown adipose tissue in adult humans. N Engl J Med (2009) 20.57

International network of cancer genome projects. Nature (2010) 20.35

Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature (2013) 20.16

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med (2013) 19.87

Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med (2008) 19.71

Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet (2008) 19.55

Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet (2011) 18.88

Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci U S A (2007) 18.83

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA (2002) 18.43

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Complement factor H polymorphism and age-related macular degeneration. Science (2005) 17.79

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell (2005) 17.41

Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet (2006) 17.36

Initial genome sequencing and analysis of multiple myeloma. Nature (2011) 17.28

Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27